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The objective of this one-institutional study was to determine the number of large-core needle biopsies (LCNB), under three-
dimensional ultrasound (3D-US) validation, that are sufficient to obtain a reliable histological diagnosis of a sonographically detectable
breast lesion. Over an 28-month period, 962 sonographically guided LCNB were performed under 3D-US validation to assess 962
breast lesions. All biopsies were carried out with an automated core biopsy device fitted with 14-gauge (22mm excursion) needles.
Data of 962 biopsied breast lesions were gathered. Surgical follow-up was available for 659 lesions. Breast malignancies were
diagnosed by ultrasound-guided LCNB with a sensitivity of 98.2% by performing three cores per lesion. In few cases, the open surgical
specimen revealed the presence of invasive carcinomas in contrast to initial LNCB-based classification as ductal carcinomas in situ
(DCIS, 11 lesions), lobular carcinoma in situ (one lesion), and atypical ductal hyperpasia (one lesion). Owing to disagreement between
classification based on breast-imaging and histological findings, eight of these tumours were subsequently excised. Of the lesions that
were removed at the patients’ requests despite benign LCNB diagnosis, two were infiltrating carcinoma and one a DCIS. We
demonstrate that three 3D-US-guided percutaneous core specimens are sufficient to achieve tissue for a reliable histological
assessment of sonographically detectable breast lesions and allow the detection of malignancies with high sensitivity and low rate of
false-negative diagnoses.
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The widespread mammography screening programmes for the
early detection of breast cancer gave rise to a tremendous number
of biopsies taken in order to determine the nature of sono- or
mammographically diagnosed breast abnormalities. In this diag-
nostic concept, a percutaneous image-guided large-core needle
biopsy (LCNB) has become an alternative to the open surgical
biopsy to remove tissue for histological assessment (Smith DN
et al, 2001; Smith WL et al, 2001; Crowe et al, 2003a; Pijnappel et al,
2004). Large-core needle biopsy can be performed either under
mammographic or sonographic guidance. In general, the sono-
graphic approach is preferred if the lesion can be visualised by
both methods. Besides the comparison of different imaging
tools, controversy has largely centred around reliability and
reproducibility of this approach (Crowe et al, 2003b), the required
amount of tissue, and the minimum number of samples which
have to be evaluated for a reliable classification of breast lesions.
Most authors suggest that five core specimens per lesion are
required for exact tumour classification (Parker et al, 1994;
Philpotts et al, 2003); however, this has not been universal practice
in clinical routine. Several studies have addressed this question
regarding stereotactic guidance and have determined five speci-
mens to be required for a reliable tumour classification (Liberman
et al, 1994; Brenner et al, 1996). To our knowledge, no comparable
large-sized study for ultrasound (US)-guided biopsy has been
performed.
In this investigation, we analysed data derived from US-guided
biopsies of 962 breast lesions in 906 patients to evaluate reliability
and reproducibility of a three-dimensional (3D) US-guided
automated LCNB technique. We demonstrated that the number
of core samples could be reduced by 3D-US-guided validated
LCNB (ensuring correct placement of the biopsy needle) without
decrease of diagnostic accuracy.
MATERIALS AND METHODS
Image-guided large-core needle biopsies of breast lesions
During a period of 28 months, 3D-US-guided biopsies were taken
from 906 patients referred to our clinic with a total of 962 palpable
or nonpalpable breast lesions that had been initially detected by
palpability, mammography, and/or ultrasound imaging. No initial
biopsies by surgical excision, stereotactic biopsy, or any other
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smeans were performed of those lesions before US-guided LCNB.
We performed a two-dimensional (2D) ultrasound examination
(Voluson 730, Kretztechnik through GE Medical Systems, Zipf,
Austria; 3D-US transducer 5–13MHz, 301 volume sector) with the
patients in supine position and elevated arms to localise the
primarily detected or additional lesions in the same or contral-
ateral breast. A sonographic classification of all lesions into benign
or malignant was performed according to characteristics that have
been described previously (Stavros et al, 1995). Prior to the first
breast biopsy, an informed consent was obtained and a history of
blood coagulation problems requested from each patient. No
laboratory tests were performed unless the patient was under
anticoagulation therapy or reported a history of coagulopathy. All
biopsies were performed by means of a core needle throw (22mm
excursion) automated biopsy gun (Bard-Magnum Biopsy Instru-
ment, Covington, GA, USA) fitted with 14-gauge needles. In order
to achieve uniformity of methods, positioning of the LCNB needle
was performed exclusively by three persons who had undergone
dedicated training in LCNB techniques. The procedure was carried
out strictly according to a standard protocol described previously,
except the number of core specimen per biopsy (Parker et al,
1993). After the needle had been placed at the edge of the lesion
under 2D-US guidance (pre-firing position), the 22mm core needle
throw was executed. Then, a 3D-US volume data set (10Mb) was
acquired and converted into a multi-planar imaging display to
define the precise post-firing position of the needle (Figure 1). If a
biopsy was recognised to be marginal or out of the lesion,
additional biopsies were taken until at least two biopsies were
central hits.
Whenever patient’s concerns persisted despite a core biopsy
with benign histology, either LCNB was repeated or an open
surgical biopsy was carried out. In all other cases with benign core
biopsy results in accordance with US images, follow-up mammo-
graphy or US examination at 3-month intervals was recommended
in accordance with the results of previous studies (Parker et al,
1994; Philpotts et al, 2003).
Classification of lesions and generated data sets
Six parameters were recorded for all of the lesions: size (calculated
longest diameter), palpability, sonographic classification, number
of specimen per lesion, histological findings at LCNB, and excision
biopsy. Of the four defined histological categories, the first was
assigned to malignant lesions (infiltrating ductal, medullary,
tubular, lobular, mucinous, papillary or other invasive carcinomas,
not defined were lymphomas or metastatic diseases). The second
category included all grades of ductal carcinomas in situ (DCIS).
Since the differentiation between low-, intermediate-, or high-
grade DCIS on the basis of small LCNB samples is an awkward
task, no differentiation of grading was carried out. Category 3
included the so-called high-risk lesions like lobular carcinoma in
situ (LCIS) and atypical ductal hyperplasias (ADH). Category 4
included benign lesions: fibroadenomas, areas of fibrocystic
changes, scar and fat tissues, papillomas, and other benign lesions.
Core needle biopsies with uncertain histological finding due to an
insufficient amount of tissue were assigned to a separate group, all
of which underwent surgical excision.
Agreement between surgical specimen or clinical follow-up and
histological findings based on LCNB was assessed. Disagreement
between histological finding in the LCNB and sonographic
classification of the lesion in breast imaging was considered an
indication for a subsequent excision biopsy. As a consequence,
lesions expected to be malignant according to sonographic criteria
that have been previously described (Stavros et al, 1995) were
removed completely by open surgery even if LCNB-based
histological evaluation had suggested a benign abnormality. All
patients for whom core biopsy revealed ADH, LCIS, or DCIS
underwent subsequent open surgical biopsy.
To describe the degree of agreement, three categories were
defined: (1) cases with complete agreement between surgical
specimen or clinical follow-up and LCNB specimen, (2) cases
with disagreement between surgical biopsy findings and examina-
tion of LCNB specimen; and (3) cases with partial agreement,
Figure 1 Multiplanar imaging based on a 3D-US volume data set during ultrasound-guided 14-gauge automated core biopsy proves that needle has
transversed mass as central hit.
Ultrasound-guided large-core needle biopsy of the breast
G Sauer et al
232
British Journal of Cancer (2005) 92(2), 231–235 & 2005 Cancer Research UK
C
l
i
n
i
c
a
l
S
t
u
d
i
e
sincluding those in which ADH was diagnosed on the basis of
LCNB but DCIS or invasive carcinoma (high risk lesions under-
estimates) concluded from the surgical biopsy, and DCIS that
were later diagnosed to possess an invasive component (DCIS
underestimates).
Statistical analysis
Overall and parameter-specific diagnostic yields were assessed,
and comparison between LCNB specimen and histological finding
at excision biopsy or clinical follow-up was determined with
McNemar’s test. Sensitivity and specificity of the LCNB technique
to yield a diagnosis were calculated. For patients with benign
LCNB results that did not undergo excision, follow-up imaging or
cross-reference with other hospitals and cancer databases was
performed to determine whether malignant lesions were subse-
quently diagnosed.
RESULTS
Of the 962 lesions, 603 (63%) were malignant, two (0.2%) high-
risk, 353 (37%) benign, and four (0.4%) insufficient for diagnosis
at LCNB specimen. Of the 603 malignant specimens, 584 were
infiltrating carcinoma and 19 DCIS; of the high-risk lesions, one
was a LCIS, the other an ADH. In 659 cases, surgical follow-up by
means of an excision biopsy was performed where the lesion was
totally removed. Surgical excision yielded 615 malignancies (609
infiltrating carcinoma, seven DCIS) and 44 benign lesions
(Figure 2). Of the 609 infiltrating carcinoma, 11 have been
assigned to be DCIS (DCIS underestimates) and two high-risk
lesions (high-risk underestimates) at LCNB specimen. Three cases
also came out to be invasive, where LCNB did not yield sufficient
material for diagnosis. Overall histological agreement between the
LCNB specimen and finding at excision biopsy was highly
significant (P¼0.001). Two patients refused excision biopsy,
where LCNB specimen showed DCIS or insufficient tissue for
reliable tumour classification. The observed high cancer rate in
this series reflects the fact that only lesions were biopsied where
breast imaging yielded a lesion of BI-RADS III or higher. The
average size was 2.5cm (median 2.2cm; range 0.2–11cm). The
sizes between benign and malignant lesions were statistically not
different. In all, 236 lesions were palpable, 726 were not, without a
difference between benign and malignant.
For the diagnostic assessment of 962 breast lesions, 2.044 3D-
US-guided core specimens were obtained in a period of 28 months.
In most (730, 75.9%) cases, two biopsies per lesion were sufficient
to obtain a clear and reliable histological result. Only one core was
taken in 31 (3.2%), three in 165 (17.2%), four in 12 (1.2%), and five
in two (0.2%) of the sonographically detectable lesions. In few (22,
2.3%) cases, the number of biopsies was not available. The
sensitivity of LCNB under 3D-US guidance to identify infiltrating
breast lesions was 96.1% (24/616), the specificity 100%. The
average of follow-up was 22.2 months (median 21; range 8–36
months). However, not following our recommendation to come in
3-month intervals for follow-up examinations, not all patients had
returned for re-evaluation despite their remaining risk of
misdiagnosed lesions. In all, 34% (121/353) patients with benign
lesions have not returned for follow-up. For these patients, cross-
reference with other institutions was performed, and no case of
breast cancer was found. However, since cancer databases might
not be 100% reliable, those 121 cases were excluded from statistical
analysis. This did not alter the results. Three patients who
underwent re-examination in our hospital for follow-up showed
an increasing lesion size and subsequently underwent excision
biopsy that yielded a benign diagnosis.
Among the 962 analysed lesions, almost all (603 of 616; 97.9%)
malignancies were identified by LCNB and immediately surgically
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Figure 2 Follow-up outcome of all breast lesions sampled by LCNB (n¼962). *One patient refused excision biopsy despite LCNB-based DCIS diagnosis.
**One patient refused excision biopsy despite inconclusive LNCB diagnosis. ***Three of these patients underwent subsequent surgery which confirmed
benign lesions, all others were without any changes.
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sexcised as a consequence. Of the 55 lesions that have been
classified by LCNB to be benign, 29 lesions were determined to be
BI-RADS IV and V lesions by breast imaging. Therefore, excision
biopsy was carried out and yielded eight malignancies (seven
infiltrating carcinoma, one DCIS) and 21 benign lesions. Of 23
breast tumours where LCNB and breast imaging yielded a benign
diagnosis, and which have been removed, three came out to be
malignant in the surgical specimen (two infiltrating carcinoma,
one DCIS).
Analysis of data from surgical follow-up, performed in 659 of the
lesions, revealed complete agreement between histological findings
in LCNB and subsequent open surgical biopsies for 635 (96.2%)
lesions. Partial agreement was found in 13 (2%) and clear
disagreement only in 11 (1.8%) of the 659 excised lesions
(Figure 2). Those 11 malignant lesions that were initially
misdiagnosed by LCNB consisted of nine infiltrating carcinoma
and two DCIS (Table 1).
All 11 LCNB misses occurred in lesions that were sonographi-
cally classified as masses and central hits of the needle. Eight of
these lesions appeared as BI-RADS IV or V lesions in breast
imaging and underwent subsequent excision biopsy (confirmed
seven invasive tumours and one DCIS) because of disagreement
between sonographic and histological finding in LCNB specimen.
Only three lesions classified as benign by means of breast imaging
and LCNB came up to be malignant (two invasive cancers, one
DCIS) at excision biopsy. None of the recorded parameters like
lesion size, palpability or number of biopsies was significantly
different in the group of malignant lesions not recognised by
LCNB-based diagnosis.
Half of all masses (51.4%) were larger than 20mm, 36.8% were
between 10 and 20mm, and 11.8% smaller than 10mm.
Clinically significant complications (that required additional
medical intervention as a consequence of the biopsy) occurred in
one (0.1%) of all biopsied patients: an infection required surgical
drainage and antibiotic treatment. Cases of minor interstitial
haemorrhage, ecchymosis, or self-limiting inflammation were not
considered to be significant complications.
DISCUSSION
Large-core needle biopsy is considered the gold standard
procedure for diagnosis of palpable and nonpalpable breast
lesions, preferred because it allows a characterisation of benign
and malignant lesions by histological examination (Parker et al,
1994; Philpotts et al, 2003; Pijnappel et al, 2004). In comparison,
fine-needle-aspiration (FNA) which yields a cytological specimen
shows a higher percentage of inconclusive results up to 29%
(Klijanienko et al, 1998). This is a known disadvantage of this
method. A multi-institutional clinical trial to evaluate different
strategies of image-guided breast intervention showed a percen-
tage of insufficient samples between 22 and 46% (Pijnappel et al,
2004). Furthermore, the success of FNA is operator dependent and
relies on pathologists with a profound knowledge in cytopathol-
ogy. This is in accordance with other studies (Pisano et al, 1998;
Farshid and Rush, 2003). However, the major problem of FNA is
the fact that it is not capable of distinguishing between DCIS and
infiltrating carcinoma, mostly resulting in a DCIS overestimation
rate (Pijnappel et al, 2004). Since there is a difference in treatment
of DCIS and infiltrating carcinoma with respect to axillary
lymphonodectomy, this is a serious clinical problem.
US-guided LCNB in a large number of patients has first been
described and evaluated in a multi-institutional study by Parker
et al (1994), who used an automated core biopsy device fitted with
14-gauge needles. Needle guidance was accomplished by means of
either a stereotactic device or ultrasound imaging. Subtracting
those that have been biopsied stereotactically by mammographic
guidance, 1408 breast lesions were biopsied in 20 different
institutions under ultrasound control. The false-negative rate of
4% was similar to that of the open surgical biopsy, for which 0.2–
20% was reported (Rissanen et al, 1994; Jackman and Marzoni,
1997; Pijnappel et al, 2004). However, previously published studies
lack consistent data indicating how many biopsies are necessary to
achieve a reliable histological finding. There is only one study on a
small number of 73 breast lesions that pays attention to that
question (Fishman et al, 2003). This investigation consisted of 14
malignant and 59 benign lesions. They conclude that at least four
cores have to be obtained to get a reliable diagnosis.
We demonstrate the results from 962 LCNB and show that three
core needle samples, which were validated by 3D-US to confirm
the correct placement of the biopsy needle, are sufficient for a
reliable histological classification of breast tumours. We use a
multi-planar display to define the precise post-firing position of
the LCNB track, because needle visualisation by 2D within a lesion
may be somewhat more subjective and be influenced by partial-
volume effects towards the periphery of the lesion that might
reduce the yield for small lesions. Furthermore, longitudinal
visualisation of the complete needle track is mostly not carried out
in the daily routine. The additional orthogonal plane, however,
yields the multi-planar visualisation of the 3D ultrasound, proves
the proper placement of the LCNB needle, and can be documented.
This information cannot easily be replaced by only turning the
probe by 901 (Weismann et al, 2000; Smith DN et al, 2001; Smith
WL et al, 2001).
The false-negative rate of 3.9% (24 out of 615) and the number
of insufficient samples of 0.4% in our study (four cases: one patient
refused, the other three underwent excision biopsy; those cases
have been excluded from statistical analysis) confirmed the results
Table 1 Characteristics of single cases of core needle biopsy misses (complete disagreement)
Sonographic
appearance Palpability
Histological finding at core
needle specimen
Histological finding at
surgical specimen
Lesion
diameter
Number of
cores
1 Suspect No Scar-tissue Infiltrating ductal carcinoma 15 2
2 Suspect No Scar-tissue Infiltrating papillary carcinoma 10 2
3 Suspect No Inflammation Infiltrating ductal carcinoma 18 2
4 Benign Yes Fibrocystic change Ductal carcinoma in situ ND
a:3
5 Benign Yes Inflammation Infiltrating ductal
carcinoma
32 3
6 Benign Yes Scar tissue Infiltrating carcinoma
b 55 3
7 Suspect Yes Fat tissue Infiltrating mucinous carcinoma 28 5
8 Suspect Yes Fat tissue Infiltrating ductal carcinoma 28 2
9 Suspect No Scar tissue Infiltrating ductal carcinoma 7 2
10 Suspect Yes Scar tissue Infiltrating ductal carcinoma 25 3
11 Suspect No Fibrocystic change Ductal carcinoma in situ 22
aND: no data.
bNot further classified. The bold characters are used to emphasise groups of cases containing true core needle biopsy misses.
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sof other investigations (Parker et al, 1994; Lee et al, 1999; Pijnappel
et al, 2004). Besides lesions that could undoubtedly be classified as
benign or malignant, there is a fraction (termed histological
underestimates) of histological findings allowing only an incom-
plete characterisation of the pathology. In this study, the LNCB-
based diagnoses of the 11 DCIS (58%) underestimates for which
subsequent analysis of the surgical specimen revealed invasiveness
were higher than in other studies (Fishman et al, 2003; Philpotts
et al, 2003; Pijnappel et al, 2004).
Obviously, there is a certain small risk of misdiagnosing a DCIS
lesion to be an ADH, or malignant lesions to consist only of ADH
or LCIS (two in our study) on the basis of small samples, which
indicates the need for an open surgical approach in ADH and
DCIS-classified cases. This is in accordance with the recommenda-
tion of consequent surgical intervention to remove all lesions of
these types (Yeh et al, 2003). Invention of such general treatment
strategy to avoid underestimation of some lesions would have
reduced the false-negative rate in our study further from 3.9% (24
out of 615) to 1.8% (11 out of 615); the sensitivity would have
increased to 98.2%, with a constant specificity of 100%. The high
sensitivity achieved in this study with 3D-US-guided LCNB also
reflects that patients with microcalcifications, for which this
technique may not be feasible, were not included and always
biopsied under mammographic guidance.
Nine invasive cancers were found by open surgical biopsy
despite benign diagnosis after core needle biopsy. Since that
histological finding was not in concordance with a suspicious
sonographic appearance, eight of these patients underwent open
biopsy that revealed seven invasive cancers and one DCIS.
Subtracting these cases in which combined information of both
breast imaging and the LCNB eventually resulted in the
identification of malignant lesions, only three remaining cases of
true core misses (two invasive cancers, one DCIS) would have led
to false-negative diagnosis and subsequent suboptimal treatment
of the patients. Fortunately, one of these lesions was removed at
the patient’s request and two as a consequence of complementary
diagnosis.
Reasons to obtain a sufficient, but not excessive, number of
biopsy samples include the minimisation of procedure time,
patient discomfort, and breast trauma. Compared to surgery, it is
less invasive and causes minimal to no scarring. This is an
important issue in view of problems to assess scar tissue accurately
in breast imaging. In our study, five of 11 (45%) core misses were
observed in scars from former excision biopsies (more than 1 year
before) where either sonographic assessment of the lesion or
visualisation of the needle was impaired. This is supported by our
observation that five of the 11 core biopsy misses later diagnosed
to be invasive carcinomas had been expected to be scar tissue from
former surgeries.
Nevertheless, LCNB is considered to obviate unnecessary
surgery for many women with benign breast lesions by warranting
a reliable histological finding, since 70–80% of breast lesions
referred for biopsy in a nonselected collective of patients are
benign (Rissanen et al, 1994; Crowe et al, 2002).
In conclusion, we demonstrate that at least three core needle
biopsies performed under 3D-US validation are sufficient to
obtain a reliable histological diagnosis of breast lesions. This
technique could, therefore, replace surgical biopsy as the standard
technique to remove tissue for initial histological assessment of
breast lesions.
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